What Medicinal Chemists need to know about Biology II

GBP

SCI, London, UK
Thursday 27 September 2018
Organised by SCI's Young Chemists' Panel

Click here to go to "Book Me On Event" button.

Synopsis

After the success of the opening installment last year, 2018 will see the return of 'What Medicinal Chemists Need to Know about Biology', the exciting and informative new series of conferences aimed at bridging the gap between medicinal chemistry and biology. This second event in this series, designed to aid chemists in understanding the features and challenges of the biological aspects of pharmaceutical research, will focus on the in vivo aspects of drug discovery biology, including topics such as:

Experienced speakers from leading pharmaceutical companies will deliver informative and interactive lectures, backed up by relevant case studies.

Attendees

The event is aimed at organic chemists (graduate or PhD) working within a pharmaceutical research environment and students thinking about a career in this sector. Participants are provided with a booklet containing the material presented. Attendees need not have attended part 1 in 2017.

SCI Members attending this meeting are able to claim CPD points.

CPD

Programme

09.15 Registration and refreshments
   
09.55 Opening remarks
   
10.05 An introduction to in vivo pharmacology in drug discovery
Alex Vugler, UCB UK
   
10.55 What makes a good target? Identification and validation of targets for drug discovery
Peter Joyce, Grey Wolf Therapeutics
   
11.45 Refreshment break
   
12.10 Preclinical and clinical utilisation of biomarkers in oncology drug discovery
Chris Morrow, AstraZeneca
   
13.00 Lunch and exhibition
   
14.00 Synaptic Vesicle Protein 2A (SV2A): from phenotypic screen and target identification to drug approval and biomarker development
Joel Mercier, UCB Belgium
   
14.55 Following the pharmacological audit trail:  from binding to efficacy with CHK1 inhibitors
Ian Collins, Institute of Cancer Research
   
15.50 Refreshment break
   
16.20 Application of in vivo PKPD to determine target engagement and mechanism of action for anti-inflammatory projects
Simon Peace, GlaxoSmithKline
   
17.15 Final Q&A and closing statements
   
17.30 Networking and refreshments

Organising Committee

Exhibition and Sponsorship

An exhibition will take place alongside the conference for companies and related organisations who may wish to exhibit. Please email conferences@soci.org for further information and prices. Spaces are limited and will be allocated on a first-come, first-served basis.

Venue

SCI
14/15 Belgrave Square
London
SW1X 8PS

Please click here for a location map.

Delegate Fees

Early bird fees before Tuesday 4 September 2018

£125   SCI Member
£40   SCI Student Member
£65   SCI Subsidised Member

£170

  Non-Member

Standard fees after Tuesday 4 September 2018

£175   SCI Member
£55   SCI Student Member
£90   SCI Subsidised Member
£240   Non-Member

SCI Platinum Corporate Members receive 25% off the above rates.

Did you know that as an SCI member you can save on this and future event delegate fees?
Join SCI now; individual membership is only £90 pa (£75 pa direct debit). To find out more click here.

For booking terms and conditions click here.

For more information, please contact:

SCI logo

Conference Team
T: +44 (0)20 7598 1561
E: conferences@soci.org

Sponsors

AstraZeneca

Related Events